2019 in Review – Major Acquisitions, Population Studies, Gigantic Founding Rounds, Technological Advancements, and ….
Nebion Provides Curated Omics Data Combined with Innovative Visualizations for Target Discovery, Indication Finding, and Drug Safety Assessment
Mike Pellini, Section 32: “I hope we will find a way where the payers and the healthcare industry will work much more closely together to generate the data that will ultimately be useful in answering difficult, cost-based decisions.”
BioIT 2019: The New “Official” Future Involves Data Sharing, Artificial Intelligence, Open Source, and More
Blueprint Genetics Aims to Automate and Improve Clinical Interpretation Processes with Software That Will Change the Industry